Congenital Hypofibrinogenemia

Congenital hypofibrinogenemia is a rare blood problem that a person is born with. In this condition, the blood has a lower-than-normal level of a protein called fibrinogen. Fibrinogen helps the blood form a strong clot when you bleed. 1 The low fibrinogen level happens because there is a change (mutation) in one of the three fibrinogen genes (FGA, FGB, or FGG). These genes tell the liver how to make fibrinogen. When one gene does not work well, the liver makes less fibrinogen, so the blood level goes down. 2

Congenital hypofibrinogenemia is a rare inherited bleeding disorder. In this condition, the liver makes less fibrinogen than normal. Fibrinogen (also called factor I) is a blood protein that helps form a firm blood clot when a blood vessel is injured. When fibrinogen is low, clots are weak and bleeding can last longer than normal. []

Doctors call it a quantitative fibrinogen disorder. It usually happens because one of the three fibrinogen genes (FGA, FGB, FGG) has a harmful change (mutation). The healthy gene copy still works, so the body makes some fibrinogen, but the level in blood is low. []

People with congenital hypofibrinogenemia can have very different symptoms. Some have almost no problems. Others have nosebleeds, heavy periods, easy bruising, bleeding after surgery or childbirth, or rarely, dangerous bleeding inside the brain or belly. Surprisingly, some people can also have blood clots (thrombosis), even though their fibrinogen level is low. []

People with congenital hypofibrinogenemia can have bleeding, no symptoms at all, or sometimes even unwanted clots (thrombosis). This is because very low fibrinogen can cause bleeding, but abnormal clot breakdown can also let clots grow in the wrong place. 3

This condition is life-long. It is different from “acquired hypofibrinogenemia,” which is caused later in life by severe liver disease, sepsis, or a serious clotting problem such as disseminated intravascular coagulation. 1

---

Other names

Doctors use several names for congenital hypofibrinogenemia. Most of them mean “inherited low fibrinogen.” 1

• Hereditary hypofibrinogenemia – “Hereditary” means passed down in a family. 2

• Congenital fibrinogen deficiency – hypofibrinogenemia type – Part of the group called congenital fibrinogen deficiencies. 3

• Quantitative fibrinogen disorder (type I fibrinogen deficiency) – “Quantitative” means the amount is low, not that the protein is abnormal in shape. 4

• Familial hypofibrinogenemia – Used when several family members have the same low fibrinogen level. 4

• Congenital fibrinogen disorder with reduced level – A general term that again points to low fibrinogen from birth. 1

All of these names describe the same basic idea: a person is born with too little fibrinogen in the blood because of a change in one fibrinogen gene. 2

---

Types of congenital hypofibrinogenemia

Experts describe several “types” or patterns inside congenital hypofibrinogenemia. These types are based on how the gene change acts and how the patient looks clinically. 1

• Simple heterozygous hypofibrinogenemia
  One copy of a fibrinogen gene is changed, and the other copy is normal. Fibrinogen level is mildly or moderately low. Many people in this group have no bleeding and are found only by routine blood tests or family screening. 4

• Hypofibrinogenemia with mainly bleeding problems
  Some gene changes lead to lower fibrinogen levels and a stronger bleeding tendency. These people may bruise easily or bleed more with surgery, trauma, or childbirth. 1

• Hypofibrinogenemia with bleeding and thrombosis
  In some families, the same low fibrinogen level can cause both bleeding and unwanted clots. The reason is complex and relates to how fibrin helps clots form and later break down. 4

• Hypofibrinogenemia with fibrinogen storage disease
  In these patients, the faulty fibrinogen builds up inside liver cells. This can cause low fibrinogen in blood and sometimes liver problems, such as raised liver enzymes or an enlarged liver. 3

• Hypofibrinogenemia as part of the wider “congenital fibrinogen deficiency” group
  Doctors often group hypofibrinogenemia together with afibrinogenemia (no fibrinogen) and dysfibrinogenemia (abnormal fibrinogen shape). This helps them choose tests and treatment, but the exact subtype still matters. 2

---

Causes

The basic cause is always a change (mutation) in a fibrinogen gene. Below are 20 simple “cause lines” that describe how this can happen or why it appears in a family. 1

1. Heterozygous FGA gene mutation
   A single harmful change in the FGA gene reduces how much Aα chain is made. With fewer Aα chains, less complete fibrinogen is formed, so the blood level is low. 4

2. Heterozygous FGB gene mutation
   A change in one FGB gene copy lowers production of the Bβ chain. This reduces the number of full fibrinogen molecules and causes hypofibrinogenemia. 1

3. Heterozygous FGG gene mutation
   A change in one FGG gene copy decreases the γ chain. Again, the body cannot assemble enough normal fibrinogen, so fibrinogen level drops. 4

4. Compound heterozygous mutations in fibrinogen genes
   Some patients inherit two different harmful changes, often one from each parent. Together, these changes reduce fibrinogen production more strongly. 1

5. Nonsense mutations
   A nonsense mutation puts an early “stop” signal in the gene. The cell then makes a short, useless chain that is destroyed, so less fibrinogen reaches the blood. 1

6. Missense mutations
   A missense mutation swaps one amino acid for another. The chain may fold badly, so the cell throws it away or it cannot join the other chains to form full fibrinogen. 4

7. Splice-site mutations
   These changes sit at the places where the gene is cut and joined. The cell then builds the message (mRNA) in the wrong way, so the finished chain is missing pieces or is unstable. 4

8. Frameshift mutations (small insertions or deletions)
   Adding or losing a few DNA letters shifts the “reading frame.” The rest of the chain is wrong, usually ending early, so it cannot make good fibrinogen. 1

9. Large gene deletions
   In some families, a big piece of a fibrinogen gene is missing. The body cannot make that chain at all, so fibrinogen levels fall. 2

10. Mutations that block fibrinogen assembly
    Some changes let the cell make chains but stop them from joining into the full six-chain fibrinogen molecule. These single chains are removed, so very little fibrinogen is secreted. 1

11. Mutations that block fibrinogen secretion (storage disease)
    In fibrinogen storage disease, mutant fibrinogen gets stuck inside liver cells and forms clumps. This lowers blood fibrinogen and can slowly hurt the liver. 3

12. Mutations that make fibrinogen unstable in blood
    Some variants are made and secreted but break down quickly in the blood, so levels stay low even though the liver is working hard. 4

13. Consanguinity (parents related by blood)
    When parents are related, they are more likely to carry the same rare gene change. A child may then inherit that change and show hypofibrinogenemia. 2

14. Strong family history of congenital fibrinogen deficiency
    If several family members have low fibrinogen, it points to a shared inherited gene change that “causes” the pattern in that family. 1

15. Founder mutations in certain populations
    In some regions, one old mutation spread through many generations. People from that group then have a higher chance of carrying that same fibrinogen gene change. 4

16. New (de novo) mutation in the child
    Sometimes the change happens for the first time in the egg or sperm. The child can have hypofibrinogenemia even though both parents have normal clotting tests. 1

17. Combination with qualitative fibrinogen defects
    A person can have both low fibrinogen and an abnormal fibrinogen molecule. This mixed state can act like a “cause” of a more complex clinical picture. 1

18. Regulatory region mutations
    Changes in gene “switch” areas (promoters or enhancers) can turn down the gene. The liver then makes less fibrinogen, even if the protein sequence itself looks normal. 4

19. Chromosome rearrangements near the fibrinogen gene cluster
    Rarely, a big move or swap of chromosome pieces near 4q31–4q32 can disturb how the three fibrinogen genes are read, lowering fibrinogen levels. 1

20. Other genetic “modifier” genes
    Some people have extra genetic factors that slightly raise or lower fibrinogen level. When combined with a fibrinogen gene mutation, these modifiers can push the level into the hypofibrinogenemia range. 4

---

Common symptoms and signs

Not everyone with congenital hypofibrinogenemia has symptoms. Some people are found only by chance. When symptoms do appear, they usually involve bleeding, and sometimes clots. 2

1. Easy bruising
   People may notice bruises after very small bumps, or even with no clear reason. This happens because clots do not form as strongly in the tiny blood vessels under the skin. 1

2. Frequent nosebleeds
   Repeated nosebleeds, especially in childhood, are common. The nose has many small vessels, and low fibrinogen makes it harder to stop the bleeding quickly. 5

3. Bleeding from gums
   Gums may bleed when brushing teeth or after dental work. The bleeding can last longer than expected. 1

4. Heavy menstrual periods (menorrhagia)
   Women with congenital hypofibrinogenemia can have very heavy or long menstrual bleeding. This may lead to tiredness or low iron if not treated. 2

5. Bleeding after cuts or small injuries
   Small cuts may ooze longer than normal before they stop. The first clot may form, but it is not firm, so bleeding restarts easily. 1

6. Prolonged bleeding after surgery or tooth extraction
   After an operation or dental extraction, these patients can bleed more and need extra treatment with fibrinogen replacement. 1

7. Bleeding around birth (umbilical stump in newborns)
   Some babies show bleeding from the cord stump or after injections soon after birth. This can be an early clue to a fibrinogen problem. 5

8. Bleeding after childbirth (postpartum hemorrhage)
   Women with low fibrinogen have higher risk of strong bleeding after delivery. Doctors often plan special care during pregnancy and birth. 2

9. Miscarriages or pregnancy loss
   Some women with very low fibrinogen levels may have more miscarriages. Good clot formation in the placenta is important for a healthy pregnancy. 1

10. Blood in urine (hematuria)
    Pink or red urine can occur if there is bleeding in the urinary tract. This needs quick medical review to rule out other causes. 2

11. Blood in stool or black stool
    Bleeding in the stomach or intestines may show as red blood in stool or black, tar-like stool. This is serious and needs urgent care. 1

12. Joint pain and swelling from bleeding (hemarthrosis)
    Bleeding into large joints like knees or ankles can cause pain, warmth, and swelling. Repeated joint bleeds may damage the joint over time. 1

13. Muscle bleeds or deep bruises
    Bleeding inside muscles can make a firm, painful lump (hematoma). This may press on nerves or vessels if it grows. 2

14. Unwanted blood clots (deep vein thrombosis)
    Some patients develop clots in leg veins, with swelling, pain, or redness in one leg. Doctors think abnormal clot breakdown plays a role in this paradox. 4

15. Clots in the lungs (pulmonary embolism) or other organs
    A clot can move to the lungs, causing sudden chest pain, shortness of breath, or coughing blood. This is rare but life-threatening and needs emergency treatment. 1

---

Diagnostic tests

Doctors use many tests to confirm congenital hypofibrinogenemia, judge its severity, and rule out other diseases. The tests below are grouped as requested: physical exam, manual tests, lab and pathological tests, machine-based (electro-type) clot tests, and imaging. 1

Physical exam tests

1. Detailed bleeding and family history with general physical exam
The doctor asks about nosebleeds, bruises, surgery, childbirth, and family members with bleeding. Then they check the whole body for bruises, petechiae (small red spots), swelling, or signs of anemia. This simple step guides which lab tests are needed. 2

2. Skin exam for bruises and petechiae
The doctor looks closely at arms, legs, trunk, and mucosal areas for easy bruising or tiny red or purple spots. The pattern and number of these marks can suggest a clotting problem like congenital hypofibrinogenemia. 5

3. Abdominal exam for liver and spleen
The doctor gently feels the abdomen to check liver and spleen size. An enlarged liver can suggest fibrinogen storage disease, and an enlarged spleen may point to other blood problems. 3

---

Manual tests

4. Bedside observation of bleeding time (simple wound test)
Although formal bleeding time is now used less often, doctors may still observe how long it takes for a small, controlled skin prick to stop bleeding. Prolonged oozing may suggest a clotting disorder, though this test is not specific. 1

5. Tourniquet (capillary fragility) test
A blood-pressure cuff is inflated on the arm for a short time. After release, the doctor looks for new small red spots on the skin. Many new spots can mean fragile vessels or a platelet/clotting problem that needs lab tests. 2

6. Bedside monitoring of umbilical stump or wound in newborns
In newborns at risk (for example with family history), staff watch the umbilical stump or injection sites. If bleeding is prolonged or restarts, they send blood for clotting tests, including fibrinogen level. 5

---

Lab and pathological tests

7. Clauss fibrinogen activity assay
This is the key test. A fixed amount of thrombin (a clotting enzyme) is added to the patient’s plasma. The time for a clot to form is measured. A calibration curve then converts this time into a fibrinogen level. Low activity confirms hypofibrinogenemia. 1

8. Fibrinogen antigen assay (immunologic assay)
This test uses antibodies to measure how much fibrinogen protein is present, regardless of function. In congenital hypofibrinogenemia, antigen and activity are both reduced by a similar amount, giving an activity/antigen ratio near 1. 4

9. Prothrombin time (PT)
PT measures the time it takes for plasma to clot after adding tissue factor and calcium. Fibrinogen is part of the final step, so a low fibrinogen level often makes PT longer than normal. 1

10. Activated partial thromboplastin time (aPTT)
aPTT tests the “intrinsic” and common clotting pathways. Like PT, it often becomes prolonged when fibrinogen is very low, helping show that there is a general clotting problem. 1

11. Thrombin time (TT)
In this test, thrombin is added directly to plasma, and the clotting time is recorded. TT is very sensitive to low fibrinogen. A markedly prolonged TT suggests low fibrinogen or abnormal fibrinogen. 3

12. Reptilase time
Reptilase is a snake enzyme that also turns fibrinogen into fibrin. Reptilase time is prolonged in low fibrinogen but is not affected by heparin, so it helps separate different reasons for a long thrombin time. 1

13. Complete blood count (CBC) with platelets
This test counts red cells, white cells, and platelets. In pure congenital hypofibrinogenemia, these counts are usually normal, which helps separate it from other blood diseases that also cause bleeding. 2

14. Liver function tests
Blood tests such as ALT, AST, and bilirubin help show how well the liver is working. They help distinguish congenital hypofibrinogenemia from acquired hypofibrinogenemia due to liver failure or severe liver disease. 3

15. Genetic testing for FGA, FGB, and FGG
DNA from blood is analyzed to look for mutations in the three fibrinogen genes. Finding a clearly harmful mutation confirms the congenital nature of the disease and helps with family counselling. 4

16. Liver biopsy with staining for fibrinogen (in suspected storage disease)
If liver disease is suspected, a small piece of liver can be taken and examined under a microscope. Special stains can show stored fibrinogen inside liver cells, confirming fibrinogen storage disease linked to hypofibrinogenemia. 3

---

Machine-based clot tests (often called “global assays”)

(These are not nerve tests but machine tests that watch a whole clot forming and breaking. They are sometimes grouped with more advanced diagnostics.) 1

17. Thromboelastography (TEG)
TEG uses a small cup of blood and a moving pin to track how quickly a clot forms, how strong it becomes, and how it breaks down. In hypofibrinogenemia, TEG often shows weak clots with low maximum strength. 1

18. Rotational thromboelastometry (ROTEM)
ROTEM is similar to TEG but uses a rotating pin and optical detection. It can use special reagents that highlight the fibrinogen part of the clot, helping doctors see how much low fibrinogen contributes to bleeding risk. 1

---

Imaging tests

19. Ultrasound or MRI of the liver and abdomen
If liver disease or fibrinogen storage disease is suspected, imaging of the liver and abdomen can show liver size, texture, and possible complications such as cirrhosis or portal hypertension. Ultrasound is often the first choice. 3

20. CT or MRI (or ultrasound) to look for bleeding or clots
When a patient has severe headache, weakness, chest pain, or leg swelling, imaging helps find bleeding in the brain or clots in the lungs or leg veins. This is very important because congenital hypofibrinogenemia can cause both bleeding and thrombosis. 2

Non-pharmacological treatments (therapies and other measures)

These measures do not replace medicines. They are supportive steps that make bleeding less likely or easier to control.

1. Education about the disease

Learning what congenital hypofibrinogenemia is, how bleeding can start, and which situations are risky gives you power to protect yourself. Doctors and nurses can teach you warning signs, emergency steps, and when to seek hospital care. Simple written plans and teaching for family members are very helpful. []

2. Regular follow-up with a hematologist

Regular clinic visits and blood tests (fibrinogen level, PT, aPTT) help the team see if your bleeding risk is changing. The doctor can plan preventive fibrinogen replacement before dental work, surgery, or childbirth. Close follow-up also helps catch clots or liver problems early. []

3. Personalized bleeding and emergency plan

Your doctor can write a short “bleeding plan” that explains your diagnosis, target fibrinogen levels, and preferred treatment (for example, which fibrinogen concentrate and dose). You can show this plan to emergency staff so they act quickly and correctly. []

4. Avoiding high-risk trauma and contact sports

Because clots are weak, blows to the head, abdomen, or joints can cause serious internal bleeding. High-impact sports (boxing, wrestling, rugby, martial arts) are usually discouraged. Safer activities like walking, swimming, and cycling with a helmet keep you active with lower bleeding risk. []

5. Using protective gear and safe home environment

Helmets, knee and elbow pads, and safe shoes lower the chance of severe injury. At home, good lighting, non-slip bathroom mats, and avoiding sharp furniture edges help prevent falls and cuts, especially for children or older adults. []

6. Careful dental hygiene and preventive dental care

Good brushing, flossing, and regular dentist visits reduce gum disease and tooth decay, which often cause mouth bleeding. If dental work is needed, the hematologist and dentist can plan fibrinogen replacement and local measures (pressure packs) beforehand. []

7. Local pressure and cold packs for minor bleeds

For nosebleeds or small skin cuts, sitting upright, pressing firmly on the area, and applying a cold pack can slow blood flow and help clotting. This simple step often controls mild bleeding while you wait for medical advice. []

8. Medical alert identification

A bracelet, necklace, or phone card saying “Congenital hypofibrinogenemia – bleeding disorder – use fibrinogen concentrate” helps emergency staff choose the right treatment quickly if you are unconscious or cannot speak. []

9. Planned management for surgery and invasive procedures

Any operation, biopsy, or even deep dental cleaning should be planned. The team checks your fibrinogen level and gives replacement to reach a safe target level before and after the procedure. This planning greatly reduces the chance of severe bleeding. []

10. Menstrual management with non-drug strategies

For people with heavy periods, using high-absorbency pads, tracking cycles, and resting more on heavy days can help. Doctors may later add hormonal or drug therapy, but these simple steps are often the first layer of control. []

11. Pregnancy and childbirth planning

Pregnancy and delivery are high-risk times for bleeding and sometimes for clots. Planning with a high-risk obstetric team and a hematologist lets doctors schedule fibrinogen replacement and choose a safe delivery method (vaginal or cesarean) and postpartum monitoring. []

12. Physiotherapy after joint or muscle bleeding

If a large bruise or joint bleed occurs, physiotherapy after the acute phase keeps the joint mobile and reduces long-term stiffness or pain. Exercises are gentle and supervised so they do not trigger new bleeding. []

13. Genetic counseling for the family

Because the condition is inherited, speaking with a genetic counselor helps families understand carrier risk, chances for future children, and options for family testing. This supports informed decisions and early diagnosis in relatives. []

14. Avoiding unnecessary injections and blood-thinning medicines

Whenever possible, blood draws and injections should be kept to the minimum needed. Over-the-counter painkillers like aspirin and many NSAIDs can worsen bleeding and should only be used if a doctor approves. []

15. Healthy weight and regular low-impact exercise

People with congenital hypofibrinogenemia can still develop clots, especially if they have obesity, diabetes, or other risk factors. A healthy weight, regular walking, and avoiding long periods of sitting may lower clot risk. []

16. Stop smoking and limit alcohol

Smoking damages blood vessels and raises clot risk. Heavy alcohol use can harm the liver, which is already under stress in some fibrinogen disorders. Avoiding smoking and keeping alcohol very low protects both vessels and liver. []

17. Infection prevention and vaccination

Repeated use of blood products slightly increases the risk of infections. Staying up-to-date with vaccines (especially hepatitis A and B if recommended) and using clean techniques for IV lines help lower this risk. []

18. Keeping a personal bleeding and transfusion record

Writing down every bleeding event, treatment, dose of fibrinogen, and any side effects helps future doctors choose the right plan quickly and safely. Many centers provide a small booklet for this purpose. []

19. Travel planning

Before long trips, patients should discuss travel with their hematologist. They may need a letter explaining their condition, information about nearby hospitals, and sometimes carrying product or having it pre-positioned at a treatment center. []

20. Psychological support and patient groups

Living with a rare bleeding disorder can cause anxiety, fear of injury, or social limits. Counseling and patient-support groups offer emotional help and practical tips from others with the same condition. []

Drug treatments

Important: All medicines below must be prescribed and supervised by a specialist. Doses here are examples from prescribing information, not personal advice. Never start or change any medicine without your doctor.

Fibrinogen replacement products and blood components

1. RiaSTAP (fibrinogen concentrate, human)

RiaSTAP is a purified human fibrinogen concentrate given by vein (IV). It quickly raises fibrinogen levels during acute bleeding or before surgery in people with congenital hypofibrinogenemia or afibrinogenemia. Doctors calculate the dose in mg/kg using your weight, baseline level, and a target level (often ≥100–150 mg/dL), then adjust based on repeat blood tests. Main risks are allergic reactions and blood clots, so monitoring is essential. []

2. Fibryga (fibrinogen [human] concentrate)

Fibryga is another IV fibrinogen concentrate. It is approved to treat acute bleeding episodes and for surgical prevention in adults and children with congenital fibrinogen deficiency. Like RiaSTAP, dosing is weight-based and guided by target fibrinogen levels. It offers standardized fibrinogen content and lower infusion volume than plasma, but can also cause thrombosis or hypersensitivity in some patients. []

3. Fesilty (fibrinogen, human-chmt)

Fesilty is a newer human fibrinogen concentrate approved for acute bleeding in adults and children with congenital fibrinogen deficiency, including hypofibrinogenemia. Doctors aim for about 100 mg/dL for minor and 150 mg/dL for major bleeding and calculate dose using formulas from the label. Infusions are given through a pump at controlled speed. Risks are similar to other concentrates: allergy, thrombosis, and very small infection risk from pooled plasma. []

4. Cryoprecipitate

Cryoprecipitate is a plasma product rich in fibrinogen, factor VIII, vWF, and factor XIII. It is often used when fibrinogen concentrate is not available. Several units are pooled and given IV to raise fibrinogen during major bleeding or surgery. It works well but gives extra proteins and a larger volume, which can increase allergy, infection, and volume-overload risks. []

5. Fresh frozen plasma (FFP)

FFP contains all clotting factors, including fibrinogen. It can be used when fibrinogen concentrates and cryoprecipitate are not accessible or when multiple factor deficiencies are suspected. Because very large volumes may be needed, it carries higher risk of fluid overload and some transfusion reactions, so it is usually a backup option. []

Antifibrinolytic medicines

6. Tranexamic acid IV (e.g., Cyklokapron)

Tranexamic acid blocks breakdown of fibrin clots by inhibiting plasminogen activation. It is given by vein for strong mucosal bleeds or around surgery and dental procedures. Typical doses in the label are calculated per kg and repeated several times per day, but your hematologist individualizes dosing and duration. Common side effects are nausea and diarrhea; rare risk of clots exists, especially in people already at high thrombotic risk. []

7. Tranexamic acid oral (e.g., Lysteda)

Tablet forms are used for heavy menstrual bleeding or minor mucosal bleeds. They help stabilize clots on surfaces such as the uterus or mouth. Usual regimens in the prescribing information involve several doses per day during the bleeding days only. It should not be taken with some hormonal birth-control pills without careful medical review due to clot risk. []

8. Aminocaproic acid (Amicar)

Aminocaproic acid is another antifibrinolytic that reduces breakdown of fibrin clots. It can be given orally or IV for dental procedures, nosebleeds, or surgery involving mucous membranes. Dose is calculated based on weight and kidney function and spread through the day. Side effects can include nausea, muscle cramps, and rare thrombosis; careful monitoring is needed. []

Local and surgical hemostatic agents

9. Tisseel (fibrin sealant)

Tisseel is a “fibrin glue” combining human fibrinogen and thrombin. Surgeons apply it directly on surgical surfaces to seal tissues and stop local bleeding when stitches or cautery are not enough. It mimics the final step of coagulation by quickly forming a fibrin clot on the tissue surface. It is dosed by volume on the wound, not by body weight, and is only used by trained surgeons. []

10. Evicel (fibrin sealant)

Evicel is another fibrin sealant containing human fibrinogen and thrombin, sprayed or dripped onto bleeding surfaces during surgery. It is especially useful in hard-to-reach areas. Because it remains local, systemic side effects are rare, but it still has small risks of infection or antibody formation. []

11. Fibrin sealant patches (e.g., TachoSil)

These are collagen sponges coated with fibrinogen and thrombin, pressed onto bleeding tissues during operations. They form an instant clot that sticks to the organ surface. The patch size and number are chosen by the surgeon based on wound size, and they slowly dissolve over time. []

Supportive blood and anemia treatments

12. Red blood cell transfusions

Severe or repeated bleeding can cause anemia. Packed red blood cells (RBCs) replace lost red cells, improving oxygen delivery and symptoms like fatigue and dizziness. The volume and speed are guided by weight, hemoglobin level, heart status, and hospital transfusion rules. They treat anemia but do not correct low fibrinogen, so they are given together with fibrinogen replacement when needed. []

13. IV iron preparations

If chronic bleeding leads to iron-deficiency anemia and oral iron is not enough or not tolerated, IV iron (for example, ferric carboxymaltose or iron sucrose) may be used. Doses depend on weight and hemoglobin deficit and are given over one or more infusions. Correcting iron stores improves energy and supports red blood cell production. []

Hormonal control of heavy menstrual bleeding

14. Combined estrogen–progestin oral contraceptive pills

In people with heavy menstrual bleeding, combined pills can thin the uterine lining and make periods lighter and more regular. Regimens follow standard contraceptive dosing (for example, 21 active days and 7 pill-free days), but must be chosen very carefully because estrogen can increase clot risk, which may already be higher in some patients with this disorder. []

15. Levonorgestrel-releasing intrauterine system (LNG-IUS)

This device slowly releases a progestin inside the uterus and can greatly reduce menstrual blood loss after the first months. It is inserted by a gynecologist under planned fibrinogen coverage if needed. It acts mostly locally, but clot risk and other side effects must still be reviewed before use. []

16. High-dose progestin therapies (oral or injectable)

Oral or depot progestins (for example, norethindrone or medroxyprogesterone) can be used to shorten or stop heavy bleeding episodes and to manage long-term menstrual control. Doses and schedules vary widely and must be tailored by a gynecologist and hematologist working together. []

Medicines for thrombosis prevention and treatment (used with extreme caution)

17. Low molecular weight heparin (LMWH)

In rare cases where a patient with congenital hypofibrinogenemia develops a serious clot (for example, deep vein thrombosis), LMWH such as enoxaparin may be used. Dosing is weight-based and adjusted for kidney function. Doctors must balance clot control against increased bleeding risk, often while also giving fibrinogen replacement. []

18. Direct oral anticoagulants (DOACs, e.g., rivaroxaban, apixaban)

DOACs may sometimes be chosen for longer-term anticoagulation after a clot, but evidence in congenital fibrinogen disorders is limited. If used, doses follow standard regimens for venous thromboembolism and require very close monitoring, ideally in a specialized center. []

Other supportive medicines

19. Proton pump inhibitors (e.g., pantoprazole)

For patients at risk of stomach bleeding (for example, on anticoagulants after a clot), PPIs protect the stomach lining by reducing acid production. Standard once-daily dosing from prescribing information is used, with dose changes for special situations if needed. They do not affect fibrinogen but reduce one possible source of bleeding. []

20. Hepatitis B vaccination (biologic “drug” for infection prevention)

Because many patients receive plasma-derived products, hepatitis B vaccination is strongly recommended when appropriate. Doses follow national immunization schedules (for example, 3 doses over 6 months). Vaccination does not change fibrinogen levels, but it helps protect the liver and reduces risk of serious infection. []

Dietary molecular supplements (10 – supportive, not a cure)

Supplements cannot fix the genetic fibrinogen problem. They only support general health and blood-forming organs. Always discuss supplements with your doctor, because some can interact with medicines or affect clotting.

1. Oral iron

Iron is needed to make red blood cells. After repeated bleeding, iron stores can fall. Oral iron (for example, ferrous sulfate) is often taken once or twice daily with food or vitamin C to improve absorption. It helps treat fatigue and anemia but does not change fibrinogen levels. []

2. Vitamin C

Vitamin C supports collagen in blood-vessel walls and improves iron absorption from the gut. Typical supplemental doses follow standard daily recommendations unless your doctor advises more. It may slightly help bruising and wound healing but is only an add-on, not a primary treatment. []

3. Vitamin B12

B12 is essential for red blood cell production. Low B12 can worsen anemia in people who already bleed easily. Supplements are given orally or by injection according to blood tests. Adequate B12 supports normal blood formation, making it easier to cope with blood loss. []

4. Folate (folic acid)

Folate works with B12 in red blood cell production. If folate is low, anemia may be more severe. Low-dose daily tablets are commonly used when deficiency is proven or likely (for example, in pregnancy). This helps the bone marrow keep up with red cell loss from bleeding. []

5. Vitamin D

Vitamin D supports bone health and immune function. People with chronic illness often have low vitamin D. Supplements are usually given once daily or weekly according to blood levels. Better bone and muscle health can lower fall risk, which indirectly reduces bleeding risk. []

6. Zinc

Zinc is involved in wound healing and immune defense. In deficiency states, skin and mucosal healing are slower. Low-dose zinc supplements, within recommended daily limits, may support healing of cuts and surgical wounds in people who bleed easily. []

7. High-quality protein supplements

The liver needs amino acids (from protein) to make fibrinogen and other proteins. If someone cannot eat enough protein, a doctor or dietitian may suggest protein drinks or powders. These should match kidney and liver function and are not a substitute for fibrinogen replacement. []

8. Multivitamin–mineral formulas

A simple daily multivitamin may be helpful when diet is poor or appetite is low. Formulas used should avoid very high doses of vitamin E, fish oil, or other ingredients that might thin the blood; your doctor or dietitian can help choose a safe product. []

9. Calcium with vitamin D (if needed)

If bone density is low, calcium plus vitamin D may be used to support bones, especially in people who avoid impact sports and weight-bearing exercise due to bleeding risk. Strong bones help reduce fracture risk after falls. []

10. Probiotic and fiber supplements

Good gut health can improve nutrient absorption, including iron and vitamins. Probiotics and soluble fiber are sometimes used under professional guidance. They have no direct effect on fibrinogen but support overall health and regular bowel movements, which may be helpful if pain medicines cause constipation. []

Immunity-boosting, regenerative and stem-cell-related approaches

Right now, no immune-booster or stem-cell drug is approved specifically to cure congenital hypofibrinogenemia. Research is ongoing, and these ideas are mostly experimental or used only in special situations.

1. Gene therapy targeting fibrinogen genes

Scientists are exploring gene-therapy techniques to deliver working copies of fibrinogen genes (FGA, FGB, FGG) to liver cells. The aim is to let the body make normal fibrinogen on its own. Studies are still early; no approved, routine gene therapy for this condition exists yet. []

2. Genome editing (e.g., CRISPR-based research)

Laboratory research is looking at precise editing tools to correct specific fibrinogen mutations in liver cells. This might one day offer a long-term cure, but safety concerns (off-target effects, cancer risk, immune reactions) mean it remains in the research phase only. []

3. Hepatocyte or stem-cell–derived liver cell transplantation

Another idea is transplanting healthy liver cells or stem-cell–derived hepatocytes that can make fibrinogen. So far, this is experimental and limited to research settings. Whole liver transplantation is sometimes used for severe fibrinogen storage disease with cirrhosis, but not as routine treatment for isolated hypofibrinogenemia. []

4. Intravenous immunoglobulin (IVIG) in special immune complications

In rare cases, patients may develop antibodies against replaced fibrinogen or other immune problems. Doctors may then use IVIG to modulate the immune system. Dosing is based on weight and indication and is given only in hospital. This is not standard for most people with congenital hypofibrinogenemia. []

5. Colony-stimulating factors (e.g., G-CSF) if other marrow issues exist

If a person also has low white blood cells from another condition or treatment, growth factors like G-CSF may be used to reduce infection risk. They do not change fibrinogen, but they support immunity during intensive therapy, surgery, or transplantation. []

6. General immune support (sleep, vaccines, infection control)

The most practical “immune booster” remains healthy sleep, good nutrition, stress control, and up-to-date vaccines. These simple measures help the body recover from bleeds and surgery and reduce infections that might trigger emergency procedures. []

Surgeries (Procedures and why they are done)

1. Emergency surgery to control life-threatening bleeding

Sometimes a large internal bleed (for example, in the abdomen or brain) needs urgent surgery to remove blood and fix the source of bleeding. Before and during surgery, the team gives fibrinogen concentrate to reach safe target levels. This can be life-saving when bleeding cannot be controlled by medicines alone. []

2. Planned orthopedic surgery for joint or bone damage

Recurrent joint or muscle bleeds may damage joints over time. Planned orthopedic procedures (such as joint cleaning or replacement) can restore function. Surgery is timed and covered with fibrinogen replacement and antifibrinolytics to keep bleeding under control. []

3. Obstetric procedures (including cesarean section)

In some pregnancies, a cesarean section or surgical management of miscarriage is needed. In women with congenital hypofibrinogenemia, these procedures are carefully planned with fibrinogen replacement and close monitoring before, during, and after to prevent severe bleeding. []

4. Central venous catheter insertion

Patients who need frequent IV treatments may benefit from a long-term central venous line or port. Insertion is done under image guidance with fibrinogen support. This reduces the number of needle sticks and makes infusions and blood tests easier. []

5. Liver transplantation (rare, mainly for fibrinogen storage disease)

A small number of patients with severe fibrinogen storage disease develop progressive liver failure and may need liver transplantation. The new liver makes normal fibrinogen, which can correct both the liver problem and the fibrinogen deficiency. This is a major operation with significant risks and is reserved for very severe cases. []

Preventions

1. Early diagnosis in at-risk families – Testing relatives of known patients allows planning and prevention before major surgery or pregnancy. []

2. Avoid unnecessary blood-thinning drugs – Do not use aspirin, many NSAIDs, or herbal “blood thinners” unless your specialist says they are safe. []

3. Plan surgery and dental work in advance – Never have major procedures without telling the team about your diagnosis and involving your hematologist. []

4. Use protective gear for daily activities and safe sports – Helmets, pads, and safe environments reduce trauma and internal bleeding risk. []

5. Manage cardiovascular risk factors – Keeping blood pressure, blood sugar, and cholesterol controlled, and avoiding smoking helps lower clot risk. []

6. Healthy weight and activity – Avoiding obesity and staying active reduces both bleeding complications (by reducing joint stress) and clot risk. []

7. Vaccinate appropriately and use safe blood products – Vaccines and strict screening of blood products lower infection risk from transfusions. []

8. Education at school and workplace – Teachers and employers who understand the condition can help prevent dangerous activities and respond fast if bleeding occurs. []

9. Regular specialist review of therapy – Checking whether fibrinogen replacement or antifibrinolytic use is too frequent or too rare helps avoid both bleeding and clotting. []

10. Psychological support to improve adherence – Good mental health makes it easier to follow treatment plans and safety advice, reducing risky behavior. []

When to see a doctor urgently

You should seek urgent medical care (emergency department or immediate doctor visit) if you have:

• Sudden, severe headache, confusion, weakness, or vision changes (possible brain bleed or clot).

• Vomit with blood, black stools, coughing blood, or heavy nosebleed that does not stop with pressure.

• Large, rapidly growing bruises or swelling in a muscle, joint, or abdomen.

• Heavy menstrual bleeding soaking pads or tampons every hour for several hours.

• Signs of a clot: swollen, painful, red leg; sudden chest pain and shortness of breath.

• Any planned surgery, dental extraction, or childbirth – these should always be discussed with your hematologist well in advance.

These warning signs need immediate specialist review, even if you have been stable before. []

What to eat and what to avoid

What to eat (5 points)

1. Iron-rich foods – Red meat, lentils, beans, spinach, and fortified cereals help replace iron lost in bleeding and prevent anemia. []

2. High-quality proteins – Eggs, fish, lean meat, dairy, soy, and legumes provide amino acids for liver protein production, including fibrinogen. []

3. Fruits and vegetables – A variety of colored fruits and vegetables supply vitamins C, K, folate, and antioxidants, supporting vessel health and blood formation. []

4. Whole grains and fiber – Whole grains support stable energy and gut health, helping absorb nutrients like iron and B vitamins. []

5. Adequate fluids – Drinking enough water keeps blood less viscous and may help reduce clot risk, especially on long journeys or during illness. []

What to avoid or limit (5 points)

1. Excess alcohol – Alcohol can harm the liver, which makes fibrinogen, and may increase bleeding risk. []

2. Very high-dose fish oil and vitamin E supplements – Large doses can thin the blood and worsen bleeding; use only if your doctor agrees. []

3. Crash diets or severe calorie restriction – These can reduce protein and micronutrient intake, weakening muscles and immunity and making bleeds harder to recover from. []

4. Highly salty processed foods – Too much salt can raise blood pressure and strain the heart, especially if you already received large volumes of fluids or blood products. []

5. Unregulated herbal products – Some herbs (like ginkgo, garlic, ginseng) can affect clotting. Always check with your doctor before taking any herbal or “natural” product. []

FAQs

1. Is congenital hypofibrinogenemia the same as hemophilia?
No. Hemophilia usually involves factor VIII or IX problems. Congenital hypofibrinogenemia affects fibrinogen (factor I). Management uses fibrinogen replacement rather than standard hemophilia factor concentrates. []

2. Can someone have this condition and never bleed?
Yes. Many people are found only because a relative is diagnosed or a blood test is abnormal. Others have mild nosebleeds or bruises only, while some have severe bleeding. The same mutation can cause very different symptoms in different people. []

3. Why can a low-fibrinogen disorder cause blood clots?
Fibrin helps both clot formation and clot breakdown. Low fibrin may mean that early fibrin strands are not cleared properly, allowing them to grow into clots. Replacement therapy and other risk factors (like surgery or immobilization) can also add to clot risk. []

4. What fibrinogen level is considered “safe”?
There is no single number for everyone. For surgery and major bleeding, many experts try to keep fibrinogen ≥100–150 mg/dL using concentrates or cryoprecipitate. For everyday life, slightly lower levels may be accepted if the person has few symptoms. Your hematologist decides the best target. []

5. Is prophylactic (regular) fibrinogen replacement always needed?
Not always. Some patients only need treatment for bleeds or before planned procedures. Others with very low levels and frequent bleeding may benefit from regular prophylaxis. Decisions depend on personal bleeding history, lab results, and risk factors. []

6. Can women with congenital hypofibrinogenemia have children safely?
Many women have successful pregnancies and deliveries, but they are higher risk. Careful planning, regular fibrinogen monitoring, and replacement around delivery are essential. Contraception and pregnancy planning should always involve both gynecology and hematology teams. []

7. Are vaccinations safe?
Yes, but intramuscular injections may need special handling if bleeding risk is high. Sometimes a subcutaneous route or local pressure for longer after injection is recommended. Your doctor will guide the safest way to vaccinate you. []

8. Can I play sports?
Most people can do low-impact sports like walking, swimming, cycling with a helmet, and gentle yoga. High-contact or collision sports are usually discouraged because of head and internal injury risk. Ask your doctor which sports are safest for your situation. []

9. Do I need to avoid all painkillers?
No, but you should avoid aspirin and many NSAIDs unless your specialist specifically approves them. Paracetamol (acetaminophen) is often safer for simple pain, at the correct dose. Always check before starting any new medicine. []

10. How often should my fibrinogen level be checked?
This depends on how severe your deficiency is and what is happening in your life. Levels are checked more often during pregnancy, around surgery, or when starting new treatments. Your hematologist will set a schedule that fits your risk. []

11. Can congenital hypofibrinogenemia turn into another disease later?
The genetic change itself does not “turn into” another clotting disorder, but people can develop other health problems over time (like liver disease or cardiovascular risk factors) that interact with their fibrinogen deficiency. Regular follow-up helps catch changes early. []

12. Is there a cure today?
At present, there is no simple pill or injection that permanently cures congenital hypofibrinogenemia. Treatment is based on replacing fibrinogen when needed and managing risk factors. Gene and cell-based therapies are being researched but are not yet standard care. []

13. Will my children definitely have the disease?
Not necessarily. In many families, the condition is inherited in an autosomal recessive way. That means children may be healthy carriers, affected, or unaffected depending on the gene status of both parents. Genetic counseling can provide a clearer picture for your family. []

14. Can I travel or live a normal life?
With good planning, many people live full, active lives. Carry a medical alert card or bracelet, know the nearest hospital, and keep in touch with your hematology team. Avoid extreme sports and follow medical advice, but you can still study, work, travel, and have relationships. []

15. Where should I go for the best care?
Because congenital hypofibrinogenemia is rare, care at or in consultation with a specialized hemophilia/bleeding-disorder center is ideal. These centers have experience with fibrinogen concentrates, pregnancy management, and surgery planning for rare bleeding disorders. Your local doctor can usually refer you. []

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: March 05, 2025.